NASDAQ · PPCB
Propanc Biopharma, Inc.
$1.86-$0.25 (-12.08%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.42% below the high.
Loading market information…
OTC · HCLC · USD
Stock price
Quote as of Jan 2, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Health-Chem Corporation, operating through its subsidiary, Transderm Laboratories Corporation, specializes in the research, development, manufacturing, and commercialization of transdermal drug delivery systems throughout the United States. Among its key products are transdermal nitroglycerin patches, formulated to provide relief for vascular and cardiovascular symptoms linked to angina pectoris (commonly known as chest pain) via skin absorption. The company additionally offers contract research and development services to third-party clients. Health-Chem Corporation employs a multifaceted sales strategy, directly engaging with wholesalers, distributors, prominent retail pharmacy chains, mail-order pharmacies, and group purchasing organizations. Its products also reach the market indirectly through independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management firms. Founded in 1970, the company's headquarters are situated in Emigsville, Pennsylvania.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.86-$0.25 (-12.08%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.42% below the high.
$0.00$0.00 (0.0%)
PotNetwork Holdings, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Predictive Technology Group, Inc.: Healthcare · Biotechnology.
$0.00-$0.00 (-25.0%)
Invitae Corporation: Healthcare · Medical - Diagnostics & Research.
$0.00$0.00 (0.0%)
Nexeon MedSystems Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
Clarus Therapeutics Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.96% below the high.
$0.01-$0.00 (-7.41%)
Unrivaled Brands, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.79% below the high.
$0.00$0.00 (0.0%)
Wholehealth Products, Inc.: Healthcare · Medical - Specialties.
